Atlas Trials

Schizophrenia Trial of Aripiprazole

Clinical trial NCT00237913 · COMPLETED

Trial details

NCT number
NCT00237913
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-07-01
Primary completion
2005-08-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.